Author:
WeiXuan Colin Tan,Gan Yiping Emily,Taieb Alain
Publisher
Springer International Publishing
Reference108 articles.
1. Alharbi B, Alamri S, Mahdi A, et al. Dasatinib-induced hypopigmentation in pediatric patient with chronic myeloid leukaemia: a case report and review of the literature. Case Rep Dermatol Med. 2018;2018:4062431.
2. de Andrade BA, Padron-Alvarado NA, Muñoz-Campos EM, et al. Hyperpigmentation of the hard palate induced by chloroquine therapy. J Clin Exp Dent. 2017;9(12):e1487–91.
3. Arase N, Tanemura A, Jin H, et al. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma. J Dermatol Sci. 2019;95(2):80–3.
4. Baker LA, Pandya AG. Drug-induced pigmentary changes. In: Jackson-Richards D, Pandya AG, editors. Dermatology atlas for skin of colour. 1st ed. Berlin: Springer-Verlag; 2014. p. 39–43.
5. Belum VR, Benhuri B, Postow MA, et al. Characterization and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer. 2016;60:12–25.